TELA Bio (TELA) Return on Equity (2019 - 2026)

TELA Bio's Return on Equity history runs 8 years deep, the most recent figure standing at 0.72% for Q1 2026.

• In Q1 2026, Return on Equity fell 72.0% year-over-year to 0.72%; the TTM figure through Mar 2026 stood at 0.72% (down 72.0% YoY), while the FY2025 annual figure was 0.02%, down 2.0% from the prior year.
• Return on Equity was 0.72% for Q1 2026 at TELA Bio, down from 0.1% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.25% in Q3 2024 to a low of 0.72% in Q1 2026.
• Historically, Return on Equity has averaged 0.06% across 5 years, with a median of 0.02% in 2022.
• The sharpest annual moves came in 2024 and 2026: Return on Equity rose 26 bps in 2024, then sank 72 bps in 2026.
• A 5-year view of Return on Equity shows it stood at 0.02% in 2022, then climbed by 13 bps to 0.02% in 2023, then surged by 103 bps to 0.0% in 2024, then tumbled by 18088 bps to 0.1% in 2025, then plunged by 626 bps to 0.72% in 2026.
• The last three Return on Equity figures came in at 0.72% (Q1 2026), 0.1% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.